Showing results (971-980 of 1,372) with videos related to

Sort By:
Pageof 138
Biological Research|February 9, 2010
VEGFA polymorphisms and cardiovascular anomalies in 22q11 microdeletion syndrome: a case-control and family-based studyJuan Francisco Calderón, Alonso R Puga, M Luisa Guzmán, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m<sup>2</sup>Chantal Mathieu, Paresh Dandona, Andreas L Birkenfeld, et al.
American Journal of Nephrology|December 9, 2019
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes MellitusDavid Z I Cherney, Enrico Repetto, David C Wheeler, et al.
Ecology|June 11, 2021
Asymmetry of marine invasions across tropical oceansMark E Torchin, Amy L Freestone, Linda McCann, et al.
Cancers|January 23, 2024
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor TargetingEdoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, et al.
Circulation|December 1, 1994
Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi CoronaricaA Maresta, M Balducelli, L Cantini, et al.
Diabetologia|March 14, 1998
Intrarenal arteriosclerosis and impairment of kidney function in NIDDM subjectsD Boeri, L E Derchi, C Martinoli, et al.
Physics in Medicine and Biology|September 13, 2016
Realistic multi-cellular dosimetry for <sup>177</sup>Lu-labelled antibodies: model and applicationS Marcatili, A Pichard, A Courteau, et al.
Oncology|January 1, 1988
Regional pharmacokinetic selectivity of intraperitoneal cisplatin in ovarian cancerM Esposito, E Campora, M Repetto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cellsB Repetto, G Bandara, H Kado-Fong, et al.
Pageof 138